-Collaboration will leverage NeoGenomics’ large oncology diagnostic laboratory and Massive Bio’s proven-at-scale proprietary artificial intelligence platform to accelerate drug discovery and optimize ...

(December 27, 2023) Natera Inc. succeeded in obtaining a preliminary injunction against NeoGenomics Laboratories, Inc.’s medical assay test. Natera’s ongoing federal lawsuit alleges that NeoGenomics’ ...

Natera, Inc. v. NeoGenomics Laboratories, Inc., Nos. 2024-1324, -1409 (Fed. Cir. (M.D.N.C.) July 12, 2024). Opinion by Moore, joined by Taranto and Chen. Natera owns ...

NeoGenomics (NASDAQ:NEO) is set to give its latest quarterly earnings report on Tuesday, 2025-04-29. Here's what investors need to know before the announcement. Analysts estimate that NeoGenomics will ...

FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, will present four abstracts at the Association for Molecular Pathology (AMP) 2024 Annual ...

Emotional intelligence is increasingly required in today’s workplace. To help students and job candidates meet this demand and flourish professionally, Florida Gulf Coast University (FGCU) and ...

Genetic testing company Natera sued Neogenomics Laboratories Inc. for patent infringement on Friday in North Carolina Middle District Court. The court case, filed by Quinn Emanuel Urquhart & Sullivan ...

FORT MYERS, Fla. and FREMONT, Calif., April 29, 2025 /PRNewswire/ -- NeoGenomics, Inc. (NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, and Ultima Genomics, ...

FORT MYERS, Fla., January 27, 2026--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will ...

Live and archived webcasts of the sessions may be viewed on the Investor Relations section of the Company’s website at ir.neogenomics.com. NeoGenomics, Inc. is a premier cancer diagnostics company ...